US equities |
SPCX $167.25 ▲+5.22% NVDA $237.08 ▲+1.34% MU $1,065.31 ▼-0.89% TSLA $375.64 ▲+1.36% MSFT $526.51 ▲+1.74% INTC $116.79 ▼-2.13% SNDK $1,721.51 ▲+0.09% META $744.14 ▲+2.21%
FinancialContent

Articles published by BiomX

News headline image
UPDATE ON UNITS - BiomX Inc. Announces 1-for-10 Reverse Stock Split
From BiomX
Via GlobeNewswire
News headline image
BiomX Reports Second Quarter 2024 Financial Results and Provides Business and Program Updates
From BiomX
Via GlobeNewswire
News headline image
BiomX Inc. Announces 1-for-10 Reverse Stock Split
From BiomX
Via GlobeNewswire
News headline image
BiomX to Host Second Quarter 2024 Financial Results Conference Call and Webcast on August 15, 2024
From BiomX
Via GlobeNewswire
News headline image
BiomX Inc. Announces NYSE American Acceptance of Plan to Regain Listing Compliance
From BiomX
Via GlobeNewswire
News headline image
BiomX Inc. Announces Stockholder Approval for Conversion of Outstanding Series X Convertible Preferred Stock to Common Stock
From BiomX
Via GlobeNewswire
News headline image
BiomX Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
From BiomX
Via GlobeNewswire
News headline image
BiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conference and at ASM Microbe 2024
From BiomX
Via GlobeNewswire
News headline image
BiomX Reports First Quarter 2024 Financial Results and Provides Business and Program Updates
From BiomX
Via GlobeNewswire
News headline image
BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024
From BiomX
Via GlobeNewswire
News headline image
BiomX Announces Publication in Cell of Research Demonstrating Proof-of-Concept Assessment of Orally Administered Phage Treatment in Preclinical Model of Inflammatory Bowel Disease
From BiomX
Via Business Wire
Tickers PHGE